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SUMMARY
Objective: The aim of our study is to examine the
impact of comorbidity on cognitive parameters after the first
ever ischemic stroke.
Material and methods: We examined 112 patients
(aged 46 to 84 (66.67± 5.96), 69 males and 43 females) with
first ever ischemic stroke. For cognitive assessment we used
Mini Mental State Examination (MMSE), 10 word test (for
short term memory and delayed recall), Isaack’s test for
verbal fluency (VF), Geriatric depression scale (GDS),
Hamilton depression scale (HDS), Blessed dementia
information memory concentration test (revised, BDIMCT),
Benton Visual Retention test (A,E; BVRT) – number of
corrects and number of errors and Wiskonsin Card Sorting
Test (number of errors, WCST). The patients were examined
on two step model. At acute stage, after collecting medical
history, somatic and neurological examinations, MMSE, 10
words test and HDS were applied. At subacute stroke stage
(90±5 days after first stroke symptoms), all cognitive tests
were used. „STATGRAPHICS Plus 5.0 (free version)”was
used for statistical analysis.
Results: Chronic ischemic heart disease and chronic
obstructive pulmonary disease are the most important
additional risk factors for cognitive decline. Thyroid
pathology, renal failure and anemia are independently
associated with poststroke depression.
Conclusions: On the basis of these data we can
conclude that vascular risk factors are independently
associated with cognitive and emotional changes after
stroke and their effects should be assessed and taken into
account for subsequent treatment of stroke survivors.
Key words: comorbid diseases, postroke depression,
poststroke cognitive impairment, vascular risk factors.
INTRODUCTION
Stroke is well known cause for cognitive impairment
and dementia all over the world. It is strongly associated
with vascular risk factors that act not only before stroke
developing but even after that1,2.
The aim of our study was to examine the impact of
comorbidity on cognitive parameters after the first ever
ischemic stroke.
MATERIAL AND METHODS
We examined 112 patients (aged 46 to 84 (66.67± 5.96),
69 males and 43 females) with first ever ischemic stroke. Of
them, 34 (30.36%) were with basic level (below 8years) of
education, 64 (57.14%) were with formal education between
11-13 years and 14 (12.50%) were with high level of formal
education. Inclusion criteria for participation of the study
were: Clinically and laboratory verified first ischemic stroke,
lack of history or family history of dementia, moderate or
severe decompensate internal diseases or psychiatric
diseases, lack of aphasia.
For stroke assessment we used history, neurological
status and CT/MRI imaging. Comorbidity was assessed on
the basis of medical history, examinations and laboratory
data. For cognitive assessment we used Mini Mental State
Examination (MMSE), 10 word test (for short term memory
and delayed recall), Isaack’s test for verbal fluency (VF),
Geriatric depression scale (GDS), Hamilton depression scale
(HDS), Blessed dementia information memory concentration
test (revised, BDIMCT), Benton Visual Retention test (A,E;
BVRT) – number of corrects and number of errors and
Wiskonsin Card Sorting Test (number of errors, WCST). The
patients were examined in double step model. At acute stage,
after collecting medical history, somatic and neurological
examinations, MMSE, 10 words test and HDS were applied.
At subacute stroke stage (90 ±5 days after first stroke
symptoms), all cognitive tests were used.
„STATGRAPHICS Plus 5.0 (free version)”was used
for statistical analysis. Kruskal Wallis test statistics were
applied. All results were interpreted at the 95% confidential
level.
RESULTS
The numbers of patients with or without examined
comorbid diseases were summarized on table 1.
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Table 1. Comorbidity
With Without
N= % N= %
Chronic ischemic heart disease 45 40.18 67 59.82
Arterial hypertension 90 80.36 22 19.64
Arrhythmias 18 16.07 94 83.93
Chronic obstructive pulmonary disease 10 8.93 102 91.07
Thyroiditis 4 3.57 108 96.43
Renal failure 5 4.46 107 95.54
Anemia 6 5.36 106 94.64
Legend:  N – number of patients, % - percent of them.
1. Impact of heart pathology on cognitive parameters after stroke.
After correction for education and age, Kruskal – Wallis test statistics was done. The results were summarized on
table 2.
Table 2. Impact of heart pathology on cognitive parameters after stroke
CIHD AH Arrhythmias
ÌÌSÅ (À) P>0.05 P>0.05 P>0.05
MMSE (SA) KW=5.93 P=0.0149 P>0.05 P>0.05
Short term memory (À) KW=4.62 P=0.0316 P>0.05 P>0.05
Short term memory (SA) KW=7.17, P=0.0074 P>0.05 P>0.05
Delayed recall (À) P>0.05 P>0.05 P>0.05
Delayed recall (SA) KW=6.34; P=0.0118 P>0.05 P>0.05
VF (SA) KW=5.75, P=0.0165 P>0.05 P>0.05
GDS (SA) P>0.05 P>0.05 P>0.05
HDS (A) KW=5.27 P=0.0217 P>0.05 KW 9.71 P=0.0018
HDS (SA) KW=7.80 P=0.0052 P>0.05 P>0.05
BDIMCT (SA) P>0.05 P>0.05 P>0.05
BVRT Cor KW=4.99 P=0.0255 P>0.05 P>0.05
BVRT Er KW=5.62 P=0.0177 P>0.05 P>0.05
WCST Er P>0.05 P>0.05 P>0.05
Legend: MMSE – Mini Mental State Examination. VF – verbal fluency. GDS – Geriatric depression scale. HDS –
Hamilton depression scale. BDIMCT – Blessed dementia information – memory – concentration test. BVRT – Benton visual
retention test.
CIDS – chronic ischemic heart disease. AH – arterial hypertension
A – acute stage, SA – subacute stage, Cor – corrects, Er – errors, KW – Kruskal – Wallis coefficient, P – P of
Kruskal – Wallis test statistics (Pe”0.05 – no statistically significant impact, P<0.05 – statistically significant impact).
2. Impact of chronic obstructive pulmonary disease, thyroiditis, renal failure and anemia on cognitive parameters.
The results were summarized in table 3.300 / J of IMAB. 2012, vol. 18, book 3 /
Table 3. Impact of Chronic obstructive pulmonary disease, thyreoiditis, kidney failure and anemia on cognitive scales.
COPD Thyroiditis Renal failure Anemia
ÌÌSÅ (À) Ð>0.05 P>0.05 P>0.05 P>0.05
MMSE (SA) P>0.05 P>0.05 P>0.05 P>0.05
Short term memory (À) P>0.05 P>0.05 P>0.05 P>0.05
Short term memory (SA) P=0.05 P>0.05 P>0.05 P>0.05
Delayed recall (À) P>0.05 P>0.05 P>0.05 P>0.05
Delayed recall (SA) P>0.05 P>0.05 P>0.05 P>0.05
VF (SA) ÊW 6.5 P>0.05 P>0.05 P=0.05
P=0.0107
GDS (SA) P>0.05 KW 5.61 P>0.05 P=0.05
P=0.0179
HDS (A) P>0.05 KW 8.41 KW 9.18 KW 6.57
P=0.0037 P=0.0025 P=0.0103
HDS (SA) P>0.05 KW 7.87 P>0.05 ÊW 6.13
P=0.0050 Ð=0.0132
BDIMCT (SA) P>0.05 P>0.05 P>0.05 P>0.05
BVRT Cor KW 5.38 P>0.05 P>0.05 P>0.05
P=0.0204
BVRT Er KW 5.59 P>0.05 P>0.05 P>0.05
P=0.0181
WCST Er P>0.05 P>0.05 P>0.05 P>0.05
Legend: MMSE – Mini Mental State Examination. VF – verbal fluency. GDS – Geriatric depression scale. HDS –
Hamilton depression scale. BDIMCT – Blessed dementia information – memory – concentration test. BVRT – Benton visual
retention test.
COPD - chronic obstructive pulmonary disease
A – acute stage, SA – subacute stage, Cor – corrects, Er – errors, KW – Kruskal – Wallis coefficient, P – P of
Kruskal – Wallis test statistics (Pe”0.05 – no statistically significant impact, P<0.05 – statistically significant impact)
of Framingham study6.
Arterial hypertension is not an independent risk factor
for poststroke vascular cognitive impairment, although the
opposite results of other authors5,6,7. However Sachdev and
al.8 in their analysis on the problem wrote that while the
hypertension increased the risk of vascular dementia itself,
the retention of high blood pressure in already developed
dementia had protective role on cognitive functions. On the
other hand, most of them are on antihypertensive therapy and
it is more or less difficult to examine the exact effect of these
drugs on cognitive functions, moreover in literature there are
controversial data for impact of hypotension therapy on
cognition9,10. However, it is possible some of the patients
without current arterial hypertension to have in their previous
history hypertonic episodes even without their knowledge.
According to our study arrhythmia is not an
independent risk factor for cognitive decline after stroke.
However it increases the severity of acute poststroke
DISCUSSION
According to our study, we could conclude that
additional vascular risk factors play important role not only
on developing ischemic stroke itself, but on the severity of
poststroke cognitive impairment. Chronic ischemic heart
disease has the greatest influence on neuropsychological
scales, result that we have been expected. It is associated
with the disease of small brain vessels, particularly in elder
patients, who may develop vascular cognitive impairment,
even without stroke3,4,5. Stroke survivors with chronic
ischemic heart disease have lower scores on MMSE and more
severe memory impairment (verbal and visual), than patients
without, particularly in subacute stroke stage so this factor
acts not only before, but even more strong after the stroke.
The disease is associated also with poststroke depression
that is not so severe to influence cognitive domains and is
not associated with additional impairment of executive
functions. These data is in correlation with the conclusions/ J of IMAB. 2012, vol. 18, book 3 / 301
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depression, although the exact mechanism is unclear.
Similarly to the work of De Carolis and al.11, our data
suggest that chronic obstructive pulmonary disease increases
the severity of cognitive dysfunction. This fact could be
explained with the continuous brain hypoxia. It affects more
intensively verbal fluency and the retention of visual
information, which seem to be more vulnerable on hypoxic
factors.
Our results are in correlation with previous findings
on association between thyroid gland pathology and
depression12, even in compensate stage of the disease. But
there is not such association with cognitive performing. It
may be due to the small sample of patients with thyroiditis
examined.
Comparatively compensate renal failure and anemia are
predisposing factors for poststroke depression due to various
and diffuse mechanisms of action.
CONCLUSION
Comorbidity influences some cognitive and emotional
domains, although this impact is not as strong as it has been
previously assessed. Chronic ischemic heart disease and
chronic obstructive pulmonary disease are the most important
additional risk factors. Thyroid pathology, renal failure and
anemia are associated with poststroke depression. So we can
conclude that vascular risk factors are independently
associated with cognitive and emotional changes after stroke
and their effects should be assessed and taken into account
for subsequent treatment of stroke survivors and even
because of the exact risk profile of Bulgarian population13,
this should be taken into account for very specific national
treatment program.